ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Sjogren’s syndrome and diagnosis"

  • Abstract Number: 671 • 2016 ACR/ARHP Annual Meeting

    Steered Screening for Sjögren Syndrome in Patients with Sicca Syndrome. Role of Salival Beta-2 Microglogulin

    Janett Riega-Torres1, Amaury Valdés-Mancha2, Celia Sánchez-Domínguez3, Lorena Pérez-Barbosa1, Ana Arana-Guajardo4, David Vega-Morales5 and Mario Alberto Garza-Elizondo1, 1Servicio de Reumatología, Departamento de Medicina Interna del Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Monterrey, Mexico, 2Servicio de Reumatología, Departamento de Medicina Interna. Hospital Universitario “Dr. José Eleuterio González”. Universidad Autónoma de Nuevo León, Monterrey, Mexico, 3Departamento de Bioquímica, Facultad de Medicina. Universidad Autónoma de Nuevo León, Monterrey, Mexico, 4Servicio de Reumatología, Departamento de Medicina Interna del Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Monterrey, Mexico, 5Universidad Autónoma de Nuevo Léon, Monterrey, Mexico

    Background/Purpose: Sicca Syndrome patients represent a diagnostic challenge for the wide variety of etiologies that can afford it. Beta-2 Microglogulin (B2MG) is a non-glycosylated protein,…
  • Abstract Number: 3201 • 2016 ACR/ARHP Annual Meeting

    Diagnostic Value of Quantitative Sialoscintigraphy Compared to Labial Salivary Gland Biopsy in Patients with Suspected SjöGren’ Syndrome

    Maria Garcia-Gonzalez1, Maria Jesus Gonzalez-Soto2, Ivan Ferraz-Amaro1, Hiurma Sanchez1, Vanesa Hernandez1, Maria Angeles Gomez2 and Sagrario Bustabad1, 1Rheumatology, Hospital Universitario de Canarias, La Laguna, Tenerife, Spain, 2Nuclear Medicine, Hospital Universitario de Canarias, La Laguna, Tenerife, Spain

    Background/Purpose: Salivary gland dysfunction is one of the most common features of Sjögren' syndrome (SS). Sialoscintigraphy (sSC) is the only technique nowadays available to objectify…
  • Abstract Number: 2187 • 2012 ACR/ARHP Annual Meeting

    Safety of Minor Labial Salivary Gland Biopsy

    ŽIga Rotar, Alojzija Hočevar, NatašA. Gašperšič, Branka Hostnik, Anita Antolić and Matija Tomšič, Department of Rheumatology, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia

    Background/Purpose: Histopathological analysis of minor salivary glands is a part of the latest classification criteria for SS proposed by the American-European Consensus Group (AECG), and…
  • Abstract Number: 2199 • 2012 ACR/ARHP Annual Meeting

    Elevated IgG4 Serum Levels Among Primary Sjogren’s Syndrome Patients: Do They Unmask Underlying IgG4-Related Disease?

    Clio P. Mavragani1, George Fragoulis2, Dimitra Rontogianni3, Maria Kanariou4 and Haralampos M. Moutsopoulos2, 1Department of Experimental Physiology, School of Medicine, University of Athens, Athens, Greece, Athens, Greece, 2Department of Pathophysiology, School of Medicine, University of Athens, Athens, Greece, 3Department of Pathology, Evangelismos General Hospital, Athens, Greece, 4Department of Immunology, "Aghia Sophia" Children's Hospital, Athens, Greece

    Background/Purpose: To determine IgG4 serum levels in a cohort of patients fulfilling the classification criteria for primary Sjogren’s syndrome (pSS) and to explore whether they…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology